Rehabilitation and Sex Therapy to Improve Recovery After Prostate Cancer Treatment
Official title: RESTORE-PC: Rehabilitation and Sex Therapy to Optimize Recovery After Prostate Cancer Treatment: A Randomized Feasibility Trial
Run by Duke University · NCT07685249 · Data updated 2026-11-12
This study tests whether adding telehealth sex therapy to pelvic floor physical therapy helps men recover sexual function after prostate cancer treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Men only |
| Enrollment | 30 (estimated) |
| Sponsor | Duke University Academic / other |
| Locations | 1 site (Durham, North Carolina) |
| Status | Recruiting |
| Started | November 2026 |
| Main results expected | November 2029 |
| Study ends | November 2029 |
| Registry record updated | November 6, 2026 |
| Trial ID | NCT07685249 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adult men with localized prostate cancer treated with nerve-sparing surgery, radiotherapy, or cryoablation who are starting pelvic floor physical therapy and have sufficient baseline erectile function.
✕Probably not a fit
Men who do not desire or need sexual health interventions, have contraindications to telehealth, or do not engage with pelvic floor therapy may see no additional benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a two-arm, randomized feasibility trial at Duke Health enrolling adult men treated for localized prostate cancer who are starting pelvic floor physical therapy. All participants receive penile rehabilitation education and a vacuum erection device, with PDE5 inhibitors allowed as part of usual care. One group also receives ten telehealth sex-therapy sessions over six months; the other group does not. Outcomes include patient-reported urinary and sexual health measures over 24 months and qualitative interviews at 6 and 12 months to gauge feasibility and acceptability.
Why it matters
Potential benefit: If successful, adding telehealth sex therapy could improve sexual health and quality of life for men recovering from prostate cancer treatment.
How similar studies have gone: Prior pelvic floor and penile rehabilitation efforts support benefit, but adding telehealth sex therapy after prostate cancer treatment is a less-studied approach and feasibility remains to be established.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Age 18 years or older. * Biopsy-confirmed localized prostate adenocarcinoma. * Treated with nerve-sparing radical prostatectomy, radiotherapy, or cryoablation as primary index therapy for prostate cancer at Duke Health. * Initiating pelvic floor physical therapy as part of routine clinical care. * Pre-treatment International Index of Erectile Function-5 (IIEF-5) score meeting the eligibility threshold, with or without aids, determined by medical record chart review (when documented within 4 months prior to index treatment) or collected post-treatment with participant recall anchored to the month prior to treatment. Eligibility threshold for the IIEF-5 is at or above 17. * Able to read and understand English to complete patient-reported outcome measures. * Ability to provide informed consent. Exclusion Criteria * Any androgen deprivation therapy (ADT) given for prostate cancer treatment or planned during the intervention or follow-up period, including neoadjuvant, concurrent, or adjuvant ADT. * Recieved non-nerve-sparing treatment (when applicable). * Unable to engage in pelvic floor physical therapy or penile rehabilitation protocol. * Need for additional or secondary prostate cancer treatment during the intervention period. * Documented cognitive impairment or impairment that would interfere with participation. * Major psychiatric concern that would interfere with ability to consent or participate, such as schizophrenia, based on the medical record or treating clinician assessment. * Inability to complete study video visits or questionnaires. * History of prior local or systemic treatment for prostate cancer
Where it's running
-
Duke University Medical Center
Durham, North Carolina, United States Recruiting
Study contacts
- Principal investigator: Rebecca A Shelby, PhD — Duke University
- Study coordinator: Michael W Willis, BA
- Email: michael.w.willis@duke.edu
- Phone: 919-681-8437
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nurse-led pre-op education with direct physiotherapy referral to reduce leakage after prostate removal
This project sees if a one-to-one nurse-led pre-operative education session plus automatic referral to supervised pelvic floor physiotherapy reduces urinary leakage in men having radical prostatectomy.
-
Stem cells to help erectile function after prostate surgery
This phase 1/2 study tests whether injected stem cells can help men recover erectile function after radical prostatectomy for localized prostate cancer, compared to placebo.
-
Nerve-sparing prostate surgery using micro-ultrasound guidance
This study is testing a new approach to prostate surgery that uses advanced ultrasound technology to help men with localized prostate cancer keep their sexual function while effectively removing the cancer.
-
Nerve grafting technique to help preserve erectile function after prostate surgery
This study is testing a new nerve grafting technique during prostate surgery to see if it can help men keep their erectile function after the operation.
-
Laser therapy for prostate cancer treatment
This study is testing a new laser treatment for men aged 50 to 80 with low to intermediate risk prostate cancer to see if it is a safer and less invasive option than traditional surgery or radiation.
-
Helping men recover sexual function after prostate cancer surgery
This study tests two different ways to help men regain their sexual function after prostate cancer surgery to see which one works better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.